Prostaglandin analogs as inhibitors of tumor cell DNA synthesis.
D015064:16,16-Dimethylprostaglandin E2 / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy; D002478:Cells, Cultured; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D008545:Melanoma / Q000188:drug therapy; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000378:metabolism; D011455:Prostaglandins A, Synthetic / Q000627:therapeutic use*; D011459:Prostaglandins E, Synthetic / Q000627:therapeutic use*; D013329:Structure-Activity Relationship; D013997:Time Factors
D004273:DNA, Neoplasm; D011455:Prostaglandins A, Synthetic; D011459:Prostaglandins E, Synthetic; D015064:16,16-Dimethylprostaglandin E2